Navigation Links
Evaluation of a Single 1.000 mg Iron Dose as Ferric Carboxymaltose (FCM) for Fatigue Treatment in Iron Deficient Women - PREFER
Date:6/15/2012

AMSTERDAM, June 15, 2012 /PRNewswire/ --

Dr Micheal Hedenus of the Haematology Unit of the Sundsval Hospital in Sweden will present promising results on a study on a single iron dose for fatigue treatment in iron deficient women at the 17th Congress of the European Hematology Association in Amsterdam.

Fatigue and iron deficiency are prevalent among women of childbearing age. This randomised, placebo-controlled study evaluated the effect of a single intravenous 1.000 mg iron dose as ferric carboxymaltose (FCM, Ferinject®, Vifor Pharma, Switzerland) on fatigue symptoms in 294 non-anaemic, iron-deficient but otherwise healthy women with moderate-to-severe fatigue (Piper Fatigue Scale total score ≥5). Fatigue symptoms were assessed before and 7, 28, and 56 days after treatment. The fatigue score improved significantly more often in FCM- than placebo-treated patients (65.3% vs. 52.7%; p=0.03) and twice as many women in the FCM than in the placebo group (33% vs. 16%; p<0.001) achieved a 50% reduction in their fatigue. Notably, a difference in the median fatigue score was seen from Day 7 onwards. In addition to the total fatigue score, all subscores as well as mental quality of life and self-rated alertness, contentment and calmness improved in the FCM-treated women. Side effects were reported by 49% of placebo- and 57% of iron-treated women. Overall, a single well-tolerated dose of ferric carboxymaltose (1,000 mg iron) rapidly and effectively replenished iron stores and reduced fatigue symptoms in non-anaemic women with fatigue and iron deficiency. The results suggest that patients with fatigue and iron deficiency without anemia may benefit from iron replacement.

About the EHA Annual Congress

After 16 congresses and constantly increasing number of delegates, the 17th Congress of EHA is taking place in Amsterdam. Hematology is a specialty that covers everything to do with blood: its origin in the bone marrow, diseases (in the production) of blood and their treatments. The latest data on research and developments within the wide spectrum of hematology are presented.


'/>"/>
SOURCE European Hematology Association
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide With Low Levels of Nitrogen Dioxide for Heart Transplant Patient Evaluation
2. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
3. Sensing the infrared: Researchers improve IR detectors with single-walled carbon nanotubes
4. Single molecules in a quantum movie
5. Relay race with single atoms: New ways of manipulating matter
6. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
7. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
8. Riordan Clinic Research Institute Has Developed and Patented a Process for the Assessment of the Energy Metabolism in Patients with Chronic Fatigue Syndrome
9. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
10. CSL Behring Data Shows 4-Factor Prothrombin Complex Concentrate Is As Effective and a More Rapid Treatment for Vitamin K Antagonist Reversal Than Current Standard of Care
11. Upsher-Smith Currently Recruiting People With Epilepsy To Evaluate Investigational Rescue Treatment For Seizure Clusters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... 2017 , ... Dr. Asher Kimchi, Founder and Chairman of the International ... at the 22nd World Congress on Heart Disease held in Vancouver, BC, Canada. In ... Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with Co-Chairmen Dr. John A. Elefteriades ...
(Date:7/20/2017)... and PLYMOUTH, Minn., July 20, 2017   ... a personalized genetic evaluations company, today announced that ... partnership investigating a genetic mutation implicated in KCNQ2 ... the partnership for a second case involving an ... the KCNQ2 Cure Alliance and Pairnomix entered into ...
(Date:7/18/2017)... ... 18, 2017 , ... Sourcing custom glass or quartz parts can be a ... to properly execute your job can take many hours of emails, phone calls and ... designed to showcase the company’s capabilities and core custom categories, and enables you to ...
(Date:7/18/2017)... ... 2017 , ... Allotrope Foundation won the 2017 in Knowledge ... Allotrope Framework for commercial use. , The Bio-IT World Best Practices Awards ... critical role of information technology in modern biomedical research, but also to highlight ...
Breaking Biology Technology:
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
Breaking Biology News(10 mins):